Related Experiment Video
Updated: Jun 26, 2026

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
Published on: May 29, 2020
Induction of hepatitis by JNK-mediated expression of TNF-alpha
Madhumita Das1, Guadalupe Sabio, Feng Jiang
1Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Abstract:
The c-Jun NH(2)-terminal kinase (JNK) signaling pathway has been implicated in the development of tumor necrosis factor (TNF)-dependent hepatitis. JNK may play a critical role in hepatocytes during TNF-stimulated cell death in vivo. To test this hypothesis, we examined the phenotype of mice with compound disruption of the Jnk1 and Jnk2 genes. Mice with loss of JNK1/2 expression in hepatocytes exhibited no defects in the development of hepatitis compared with control mice, whereas mice with loss of JNK1/2 in the hematopoietic compartment exhibited a profound defect in hepatitis that was associated with markedly reduced expression of TNF-alpha. These data indicate that JNK is required for TNF-alpha expression but not for TNF-alpha-stimulated death of hepatocytes. Indeed, TNF-alpha induced similar hepatic damage in both mice with hepatocyte-specific JNK1/2 deficiency and control mice. These observations confirm a role for JNK in the development of hepatitis but identify hematopoietic cells as the site of the essential function of JNK.
Insights
The c-Jun NH2-terminal kinase (JNK) pathway is crucial for tumor necrosis factor (TNF)-alpha expression in hematopoietic cells, not for hepatocyte death, during hepatitis development.
Area of Science:
- Immunology
- Hepatology
- Molecular Biology
Background:
- The c-Jun NH2-terminal kinase (JNK) signaling pathway is involved in tumor necrosis factor (TNF)-dependent hepatitis.
- JNK's role in TNF-stimulated hepatocyte death in vivo requires further investigation.
Purpose of the Study:
- To investigate the role of JNK1 and JNK2 in the development of TNF-dependent hepatitis.
- To determine whether JNK is essential in hepatocytes or hematopoietic cells for hepatitis progression.
Main Methods:
- Generation of mice with compound disruption of Jnk1 and Jnk2 genes.
- Analysis of hepatitis phenotype in mice with hepatocyte-specific or hematopoietic-specific JNK1/2 deficiency.
- Assessment of TNF-alpha expression and hepatic damage.
Main Results:
- Mice lacking JNK1/2 in hepatocytes showed no defect in hepatitis development.
- Mice lacking JNK1/2 in hematopoietic cells exhibited a significant defect in hepatitis.
- Hepatitis in JNK-deficient mice was associated with reduced TNF-alpha expression.
- TNF-alpha induced similar hepatic damage in both hepatocyte-specific JNK1/2-deficient and control mice.
Conclusions:
- JNK is essential for TNF-alpha expression, but not for TNF-alpha-induced hepatocyte death.
- Hematopoietic cells, not hepatocytes, are the critical site for JNK function in hepatitis development.
Related Concept Videos
Hepatitis
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The JAK-STAT Signaling Pathway
Cirrhosis II: Pathophysiology
Viral Hepatitis I: Introduction
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...

